Health & Fitness
Tue, September 4, 2012
CAMBRIDGE, Mass.--([ BUSINESS WIRE ])--[ ARIAD Pharmaceuticals, Inc. ] (NASDAQ: ARIA) today announced that it will present at the Stifel Nicolaus Healthcare conference in Boston. Timothy P. Clackson, Ph.D., president of research and development and chief scientific officer, will provide an overview of the Companyas business on Wednesday, September 5, 2012 at 4:25 p.m. (ET).
The ARIAD presentation at the Stifel Nicolaus Healthcare Conference will be webcast live and can be accessed by visiting the investor relations section of the Company's website at [ http://www.ariad.com/investor ]. A replay of the presentation will also be available and archived on the site for three weeks.
About ARIAD
ARIAD Pharmaceuticals, Inc. is an emerging global oncology company focused on the discovery, development and commercialization of medicines to transform the lives of cancer patients. ARIADas approach to structure-based drug design has led to several internally discovered, molecularly targeted product candidates for drug-resistant or difficult-to-treat cancers, including certain forms of chronic myeloid leukemia and non-small cell lung cancer. For additional information, visit [ http://www.ariad.com ] or follow ARIAD on [ Twitter ] (@ARIADPharm).
